Her2 Test: - Cancer Science

Relevant Publications

Clinical application of targeted tumour sequencing tests for detecting ERBB2 amplification and optimizing anti-HER2 therapy in gastric cancer.

Issue Release: 2024

Quality Assurance Model for Breast Cancer Prognostication Using the Modified Magee Equations.

Issue Release: 2024

The somatic mutation profile of estrogen receptor-positive HER2-negative metastatic breast cancer in Brazilian patients.

Issue Release: 2024

Attempt to Substitute the Oncotype DX Breast Recurrence Score Test by Histopathological Factors and MUC1 Protein Expression.

Issue Release: 2024

Accuracy of MRI Versus PET/CT in the Prediction of Treatment Response to Neoadjuvant Chemotherapy in Breast Cancer.

Issue Release: 2024

Randomized Phase III Study of Amcenestrant Plus Palbociclib Versus Letrozole Plus Palbociclib in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Primary Results From AMEERA-5.

Issue Release: 2024

Management of early-stage HER2-positive breast cancer and attitudes towards HER2DX test in Spain: insights from a nationwide survey.

Issue Release: 2024

Circulating microRNAs and therapy-associated cardiac events in HER2-positive breast cancer patients: an exploratory analysis from NeoALTTO.

Issue Release: 2024

Long-term prospective outcome data using EndoPredict as risk stratification and chemotherapy decision biomarker in hormone receptor-positive, HER2-negative early breast cancer.

Issue Release: 2024

High tumour-infiltrating lymphocytes correlate with distinct gene expression profile and favourable survival in single hormone receptor-positive breast cancer.

Issue Release: 2024

Radiological Features for Predicting the Status of CD8-Positive Lymphocytes in HER2 Positive Breast Cancer.

Issue Release: 2024

Histogram analysis of intravoxel incoherent motion imaging: Correlation with molecular prognostic factors and combined subtypes of breast cancer.

Issue Release: 2024

Fulvestrant en la práctica clínica: análisis de efectividad en pacientes uruguayas con cáncer de mama HR+/HER2.

Issue Release: 2024

Characterization of HER2-Low Breast Tumors among a Cohort of Colombian Women.

Issue Release: 2024

Acquired gene alterations in patients treated with ribociclib plus endocrine therapy or endocrine therapy alone using baseline and end-of-treatment circulating tumor DNA samples in the MONALEESA-2, -3, and -7 trials.

Issue Release: 2024

Inflammatory markers related to survival in breast cancer patients: Peru.

Issue Release: 2024

A Comprehensive Model Outperformed the Single Radiomics Model in Noninvasively Predicting the HER2 Status in Patients with Breast Cancer.

Issue Release: 2024

Overexpression of cytoplasmic poly(A)-binding protein 1 as a biomarker for the prognosis and selection of postoperative regimen in breast cancer.

Issue Release: 2024

The Genomic Landscape of Breast Cancer in Young and Older Women.

Issue Release: 2024

Association of hTERT expression, Her2Neu, estrogen receptors, progesterone receptors, with telomere length before and at the end of treatment in breast cancer patients.

Issue Release: 2024

What Are the Benefits of Using Transdermal Patches for Cancer Patients?

How Can Stress and Mental Health Affect Cancer Risk?

Can Dementia Affect Cancer Diagnosis and Treatment?

What About Changes in Bladder Habits?

How is Choline Kinase Linked to Cancer?

How Does the Adaptive Immune System Recognize Cancer Cells?

Are These Apps Secure?

What are Microfilaments?

How Does Acinetobacter Baumannii Spread?

What are the Symptoms of Stroke in Cancer Patients?

Her2 Test: - Cancer Science

Relevant Publications

Partnered Content Networks

Relevant Topics